EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Current and new strategies for hepatocellular carcinoma surveillance

Natchaya Polpichai iD, Chongkonrat Maneenil iD, Pojsakorn Danpanichkul iD, Chitchai Rattananukrom iD, Ashok Choudhury iD, Yu Jun Wong iD, Pimsiri Sripongpun iD, Suthat Liangpunsakul iD, Apichat Kaewdech iD

Gastroenterology Report · 11.01.2025 · 13

DOI: 10.1093/gastro/goaf045 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Gastroenterology Report, online erschienen am 06.06.2025. Verfasst von Natchaya Polpichai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Weiss Memorial Hospital, Chicago, IL, USA. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, particularly among individuals with chronic liver diseases. Early detection through surveillance significantly improves survival rates and current guidelines recommend semiannual ultrasound, with or without alpha-fetoprotein (AFP) testing, for high-risk populations. However, limitations in ultrasound sensitivity, physician adherence, and patient compliance affect the effectiveness of these surveillance efforts. This review explores both current and emerging strategies for HCC surveillance. Individualized surveillance approaches, utilizing risk stratification tools such as the aMAP and PAGE-B scores, enable tailored monitoring based on individual risk profiles, potentially reducing unnecessary screening in low-risk groups. Advanced imaging techniques, including contrast-enhanced ultrasound and abbreviated magnetic resonance imaging, demonstrate improved sensitivity over traditional ultrasound, particularly for early-stage HCC detection. Additionally, combining clinical characteristics with novel HCC biomarkers—such as the Gender, Age, AFP-L3, AFP, and Des-gamma-carboxy prothrombin (GALAD) score; HCC early detection screening score version 2 (HES V2.0) score; Gender, Age, AFP, and Des-gamma-carboxy prothrombin (GAAD) score; and AFP, Sex, Age, and Protein induced by vitamin K absence-II (ASAP) score—has shown higher sensitivity for early detection, with GALAD and HES V2.0 performing particularly well in phase 3 biomarker studies. Emerging molecular diagnostics, including liquid biopsy and genetic markers, also show promise in refining future HCC surveillance protocols. Despite these advancements, a limited number of at-risk patients currently undergo surveillance. Therefore, solutions must focus on enhancing awareness, adherence, and accessibility to surveillance tools. This review discusses various strategies for optimizing HCC surveillance, emphasizing a multifaceted approach that integrates risk-assessment tools, advanced imaging, and novel biomarkers to improve early detection and reduce mortality.

Schlagwörter

Stichwörter der Autor:innen

GALADhepatocellular carcinomalivermagnetic resonance imagingsurveillanceultrasonography

Autor:innen und Institutionen

  • Department of Internal Medicine, Weiss Memorial Hospital, Chicago, IL, USA.
  • Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
  • Department of Internal Medicine, Texas Tech University Health Science Center, Lubbock, TX, USA.
  • Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand.
  • Department of Hepatology and Liver Transplant, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Department of Gastroenterology & Hepatology, Changi General Hospital, Singapore.

ORCID-Profile: Natchaya Polpichai, Chongkonrat Maneenil, Pojsakorn Danpanichkul, Chitchai Rattananukrom, Ashok Choudhury, Yu Jun Wong, Pimsiri Sripongpun, Suthat Liangpunsakul, Apichat Kaewdech

Förderung

  • Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand

Zitieren

APA

Polpichai, N., Maneenil, C., Danpanichkul, P., Rattananukrom, C., Choudhury, A., Wong, Y. J., Sripongpun, P., Liangpunsakul, S., & Kaewdech, A. (2025). Current and new strategies for hepatocellular carcinoma surveillance. Gastroenterology Report, 13. https://doi.org/10.1093/gastro/goaf045

Vancouver

Polpichai N, Maneenil C, Danpanichkul P, Rattananukrom C, Choudhury A, Wong YJ, et al. Current and new strategies for hepatocellular carcinoma surveillance. Gastroenterology Report. 2025;13. doi:10.1093/gastro/goaf045

BibTeX
@article{Polpichai2025,
  author = {Polpichai, Natchaya and Maneenil, Chongkonrat and Danpanichkul, Pojsakorn and Rattananukrom, Chitchai and Choudhury, Ashok and Wong, Yu Jun and Sripongpun, Pimsiri and Liangpunsakul, Suthat and Kaewdech, Apichat},
  title = {Current and new strategies for hepatocellular carcinoma surveillance},
  journal = {Gastroenterology Report},
  year = {2025},
  volume = {13},
  doi = {10.1093/gastro/goaf045}
}
Kostenlos starten →